Studies carried out in several animal species have not shown any teratogenic or foetotoxic effects. However, the safety of Cefpodoxime proxetil in pregnancy has not been established and, as with all drugs, it should be administered with caution during the early months of pregnancy.
Cefpodoxime is excreted in human milk. Either breastfeeding or treatment of the mother should be stopped.
Other Services
Country
Account